A medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, or OSA. Our lead solution is the Genio system, a CE-Marked, patient-centric, minimally invasive, next generation hypoglossal neurostimulation therapy for the treatment of moderate to severe OSA.
Lead Underwriter
Cantor Fitzgerald & Co., Piper Sandler & Co, Stifel Nicolaus & Company, Incorporated
